Format
Sort by
Items per page

Send to

Choose Destination

Best matches for illicit drugs AND urine:

Search results

Items: 1 to 20 of 1626

1.

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.

Gupta N, Zhang S, Pusalkar S, Plesescu M, Chowdhury S, Hanley MJ, Wang B, Xia C, Zhang X, Venkatakrishnan K, Shepard DR.

Invest New Drugs. 2017 Sep 21. doi: 10.1007/s10637-017-0509-1. [Epub ahead of print]

PMID:
28932928
2.

[Substance abuse detection in substitution therapy : Oral fluid versus urine screening].

Stein J, Geraedts M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Sep 19. doi: 10.1007/s00103-017-2630-x. [Epub ahead of print] German.

PMID:
28929198
3.

Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats.

Beck O, Bäckberg M, Signell P, Helander A.

Clin Toxicol (Phila). 2017 Sep 12:1-8. doi: 10.1080/15563650.2017.1370097. [Epub ahead of print]

PMID:
28895757
4.

Rapid Determination of Aconitum Alkaloids from Human Urine by UHPLC-HRMS.

Li S, Chen D.

J Anal Toxicol. 2017 Sep 1;41(7):611-617. doi: 10.1093/jat/bkx045.

PMID:
28873976
5.

Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS.

Sundström M, Pelander A, Ojanperä I.

J Anal Toxicol. 2017 Sep 1;41(7):623-630. doi: 10.1093/jat/bkx044.

PMID:
28873975
6.

Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.

Forensic Sci Int. 2017 Aug 26;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. [Epub ahead of print]

PMID:
28869822
7.

Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.

Jin Y, Regev A, Kam J, Phipps K, Smith C, Henck J, Campanale K, Hu L, Hall DG, Yang XY, Nakano M, McNearney TA, Uetrecht J, Landschulz W.

Br J Clin Pharmacol. 2017 Sep 2. doi: 10.1111/bcp.13423. [Epub ahead of print]

PMID:
28865237
8.

Assessment of exposure to pesticides in rural workers in southern of Minas Gerais, Brazil.

Silvério ACP, Machado SC, Azevedo L, Nogueira DA, de Castro Graciano MM, Simões JS, Viana ALM, Martins I.

Environ Toxicol Pharmacol. 2017 Aug 18;55:99-106. doi: 10.1016/j.etap.2017.08.013. [Epub ahead of print]

PMID:
28843102
9.

LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples.

Athar Masood M, Veenstra TD.

Basic Clin Pharmacol Toxicol. 2017 Aug 26. doi: 10.1111/bcpt.12877. [Epub ahead of print]

PMID:
28843027
10.

Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.

Johnson S, Martin PR.

Am J Drug Alcohol Abuse. 2017 Aug 22:1-7. doi: 10.1080/00952990.2017.1363218. [Epub ahead of print]

PMID:
28829626
11.

Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.

Wan EYF, Fong DYT, Fung CSC, Yu EYT, Chin WY, Chan AKC, Lam CLK.

BMC Nephrol. 2017 Aug 1;18(1):257. doi: 10.1186/s12882-017-0671-x.

12.

Changes in illicit, licit and stimulant designer drug use patterns in South-East Hungary between 2008 and 2015.

Árok Z, Csesztregi T, Sija É, Varga T, Kereszty ÉM, Tóth RA, Institóris L.

Leg Med (Tokyo). 2017 Sep;28:37-44. doi: 10.1016/j.legalmed.2017.07.001. Epub 2017 Jul 8.

PMID:
28759769
13.

Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder.

Wilder CM, Hosta D, Winhusen T.

J Subst Abuse Treat. 2017 Sep;80:33-36. doi: 10.1016/j.jsat.2017.06.005. Epub 2017 Jun 23.

PMID:
28755770
14.

Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics.

Masson JF.

ACS Sens. 2017 Jan 27;2(1):16-30. doi: 10.1021/acssensors.6b00763. Epub 2017 Jan 6.

PMID:
28722437
15.

The presence of licit and illicit drugs in police stations and their implications for workplace drug testing.

Doran GS, Deans R, De Filippis C, Kostakis C, Howitt JA.

Forensic Sci Int. 2017 Sep;278:125-136. doi: 10.1016/j.forsciint.2017.06.034. Epub 2017 Jul 5.

PMID:
28715674
16.

Fast, Sensitive, and Quantitative Point-of-Care Platform for the Assessment of Drugs of Abuse in Urine, Serum, and Whole Blood.

Li Y, Uddayasankar U, He B, Wang P, Qin L.

Anal Chem. 2017 Aug 15;89(16):8273-8281. doi: 10.1021/acs.analchem.7b01288. Epub 2017 Jul 26.

PMID:
28700829
17.

Mephedrone Concentrations in Cases of Clinical Intoxication.

Papaseit E, Olesti E, de la Torre R, Torrens M, Farré M.

Curr Pharm Des. 2017 Jul 4. doi: 10.2174/1381612823666170704130213. [Epub ahead of print]

PMID:
28677506
18.

Fatalities Involving Carfentanil and Furanyl Fentanyl: Two Case Reports.

Swanson DM, Hair LS, Strauch Rivers SR, Smyth BC, Brogan SC, Ventoso AD, Vaccaro SL, Pearson JM.

J Anal Toxicol. 2017 Jul 1;41(6):498-502. doi: 10.1093/jat/bkx037.

PMID:
28575422
19.

Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.

Zhou J, Jin J, Li X, Zhao Z, Zhang L, Wang Q, Li J, Zhang Q, Xiang S.

Urolithiasis. 2017 May 31. doi: 10.1007/s00240-017-0985-y. [Epub ahead of print]

PMID:
28567512
20.

Screening with Quantification for 64 Drugs and Metabolites in Human Urine using UPLC-MS-MS Analysis and a Threshold Accurate Calibration.

Rosano TG, Ohouo PY, Wood M.

J Anal Toxicol. 2017 Jul 1;41(6):536-546. doi: 10.1093/jat/bkx035.

PMID:
28541461

Supplemental Content

Loading ...
Support Center